Stock 867 CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News China Medical System Holdings Limited

Equities

867

KYG211081248

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:42 2024-06-28 EDT 		5-day change 1st Jan Change
6.62 HKD +0.76% Intraday chart for China Medical System Holdings Limited -4.61% -52.17%
06-25 China Medical System Holdings Limited Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China CI
06-18 China Medical System Gets Drug Registration Certificate for Lesion Visualization Drug in China MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
AQ
China Medical System Holdings Limited Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
CI
Cosmo's oral diagnostic drug Lumeblue receives approval of New Drug Application in China
AQ
China Medical System Gets Drug Registration Certificate for Lesion Visualization Drug in China
MT
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
AQ
China Medical System Holdings Limited Announces Approval of Lumeblue® by NMPA for Enhanced Colorectal Lesion Detection
CI
Final dividend
FA
China Medical System Holdings Limited Approves Final Dividend for the Year Ended 31 December 2023
CI
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
AQ
China Medical System's Anti-Anaemia NDA Accepted in China
MT
China Medical System Holdings Limited Announces New Drug Application of Desidustat Tablets Accepted in China
CI
Zydus Lifesciences' Desidustat Tablets Get Nod from China Regulator
MT
China Medical System Registers New Vitiligo Drug in Macau
MT
China Medical System Holdings Limited commences an Equity Buyback for 245,198,851 shares, representing 10% of its issued share capital, under the authorization approved on April 28, 2023.
CI
Incyte, China Medical System Sign Collaboration, License Agreement
MT
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
AQ
Incyte Corporation and China Medical System Holdings Limited Announce Collaboration and License Agreement for Povorcitinib, an Oral Jak1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
CI
China Medical System （867.HK）2023 Annual Results: Despite of the Temporary Financial Performance Pressure Fresh Catalysts Emerged from Successive Innovation Breakthroughs
AQ
China Medical System Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Medical System Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on About 23 May 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 867 Stock
  4. News China Medical System Holdings Limited